Development of GPER agonists to improve healthspan
The team will test whether a compound with an established safety profile, demonstrated cardiometabolic benefits, and once-daily dosing improves aging outcomes.
The team will test whether a compound with an established safety profile, demonstrated cardiometabolic benefits, and once-daily dosing improves aging outcomes.